Skip to content
  • Instagram
logo The Onco Doc

Oncology, Reinvented for Tomorrow

Get Newsletter
  • Home
  • Blogs
  • Authors
Home » Continuing Medical Education (CME)
From Education to Engagement: How Hidoc Dr’s Ecosystem of Unnati and Medibot Redefines Oncology Medico-Marketing
Posted inPharma Marketing

From Education to Engagement: How Hidoc Dr’s Ecosystem of Unnati and Medibot Redefines Oncology Medico-Marketing

Posted by OncoDoc August 19, 2025
Abstract In the high-stakes, rapidly evolving field of oncology, the traditional model of medico-marketing—reliant on…
Read More
How Conversational AI Is Redefining Engagement for Doctors? Are Your Campaigns Missing the Unnati + MediBot Advantage?
Posted inPharma Marketing

How Conversational AI Is Redefining Engagement for Doctors? Are Your Campaigns Missing the Unnati + MediBot Advantage?

Posted by OncoDoc August 18, 2025
Abstract The oncology sector is at the forefront of medical innovation, but its marketing and…
Read More
Can AI-Driven Education Achieve 80%+ Engagement? How Unnati Is Redefining Medical Education for Pharma Partnerships in Oncology
Posted inPharma Marketing

Can AI-Driven Education Achieve 80%+ Engagement? How Unnati Is Redefining Medical Education for Pharma Partnerships in Oncology

Posted by OncoDoc August 16, 2025
Abstract In the high-stakes, rapidly evolving field of oncology, the continuous professional development and upskilling…
Read More
How are initiatives like Unnati and Medibot, from Hidoc Dr., outperforming oncology marketing?
Posted inPharma Marketing

How are initiatives like Unnati and Medibot, from Hidoc Dr., outperforming oncology marketing?

Posted by OncoDoc August 14, 2025
Abstract In the intensely competitive and regulated sphere of oncology, the pursuit of meaningful engagement…
Read More
From Clicks to Conversions: How Top U.S. Pharma Brands Are Outperforming on LinkedIn
Posted inPharma Marketing

From Clicks to Conversions: How Top U.S. Pharma Brands Are Outperforming on LinkedIn Using AI

Posted by OncoDoc August 13, 2025
Abstract In the highly regulated and competitive landscape of oncology, a strategic digital presence is…
Read More
How Can You Future-Proof Your Oncology Marketing? 3 Messaging Shifts Pharma Brand Managers Must Make Now
Posted inPharma Marketing

How Can You Future-Proof Your Oncology Marketing? 3 Messaging Shifts Pharma Brand Managers Must Make Now

Posted by OncoDoc August 12, 2025
Abstract The pharmaceutical marketing landscape is in a constant state of flux, driven by both…
Read More
DTC Ad Ban: A Ticking Time Bomb? What U.S. Pharma Marketers Must Do Now
Posted inPharma Marketing

DTC Ad Ban: A Ticking Time Bomb? What U.S. Pharma Marketers Must Do Now

Posted by OncoDoc August 11, 2025
Abstract The landscape of pharmaceutical marketing in the United States is at a critical juncture.…
Read More
Beyond the Checkbox: How Compliance is Forcing a Digital Revolution in Oncology Marketing
Posted inPharma Marketing

Beyond the Checkbox: How Compliance is Forcing a Digital Revolution in Oncology Marketing

Posted by OncoDoc August 9, 2025
Abstract The digital frontier of medical oncology marketing, once a landscape of unbridled innovation, is…
Read More
Beyond the Hype: Which Technologies Will Truly Define Oncology Marketing in 2025?
Posted inPharma Marketing

Beyond the Hype: Which Technologies Will Truly Define Oncology Marketing in 2025?

Posted by OncoDoc August 8, 2025
Abstract The rapid evolution of technology, combined with the increasing complexity of oncology care, is…
Read More
Post-Election Pharma
Posted inPharma Marketing

Post-Election Pharma: What U.S. Policy Changes Mean for Global Oncology Marketers

Posted by OncoDoc August 7, 2025
Abstract The outcome of U.S. elections often ushers in significant policy changes with far-reaching consequences…
Read More

Posts pagination

1 2 3 Next page

Stay informed. Stay ahead.
Get the latest oncology
insights and pharma
marketing trends delivered
straight to your inbox.
Subscribe to our Newsletter!

India: Infedis Infotech LLP.
1st Floor, Office No 108, S No 557 A 1 CTS No
97, Suyog Center, Gultekdi, Pune, Maharashtra
For Queries/Grievances, Contact : V. Gadia
+91-9665017922
info@hidoc.co
LLP Identification Number : AAH-8647

Infedis Health Private Limited.
Suyog Center, Office No. 108, 1st Floor, Gultekdi, Pune, Maharashtra, India - 411037
CIN of the Company : U74999PN2018PTC175141

US : Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
+1 (415) 463-3094

CSR Policy

Copyright 2025 â€” The Onco Doc. All rights reserved.
Terms & Conditions - LLP |  Inc. |  Privacy Policy - LLP |  Inc. |  Account Deactivation
Scroll to Top